C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2011
11/03/2011	WO2011081502A3 Molecular marker related to ms k (nuclear-genetic male sterility gene) and certification method using same
11/03/2011	WO2011074803A3 Method for improving performance of rt-pcr using klenow fragment
11/03/2011	WO2011071297A3 Composition for analyzing the pluripotency of pig stem cells
11/03/2011	WO2011065747A3 Rapid detection method for microorganisms using nanoparticles
11/03/2011	WO2011057034A3 Catenae: serosal cancer stem cells
11/03/2011	WO2011056872A3 Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly
11/03/2011	WO2011056866A3 Methods and kits for 3'-end-tagging of rna
11/03/2011	WO2011050050A3 Use of a high-resolution melting assay to measure genetic diversity
11/03/2011	WO2011049324A3 Analytic method and diagnostic kit for diagnosis of polycystic ovary syndrome
11/03/2011	WO2011044513A9 Diagnostic and prognostic markers for cancer
11/03/2011	WO2011044437A3 Polony sequencing methods
11/03/2011	WO2011040971A3 Generation of modified polymerases for improved accuracy in single molecule sequencing
11/03/2011	WO2011027990A3 Extracellular vesicles derived from gram-positive bacteria, and use thereof
11/03/2011	WO2010056642A3 Methods for genetic analysis of textiles made of gossypium barbadense and gossypium hirsutum cotton
11/03/2011	WO2004039831A3 Peptide nucleic acid probes for analysis of enterococcus faecium
11/03/2011	US20110271356 Hcv entry factor, occludin
11/03/2011	US20110270060 Device and methods for monitoring the administration of a stem cell transplant
11/03/2011	US20110270054 Assay for positioning a feeding tube and method thereof
11/03/2011	US20110269825 Modified Thromboxane A2 Receptor Promoter Sequence
11/03/2011	US20110269821 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
11/03/2011	US20110269819 Methods and compositions for targeting skip
11/03/2011	US20110269817 Compositions and methods related to sirt1 function
11/03/2011	US20110269813 Gene Silencing by Single-Stranded Polynucleotides
11/03/2011	US20110269812 Novel benzylidene-indolinone and their medical and diagnostic uses
11/03/2011	US20110269797 Anln protein as an endocrine treatment predictive factor
11/03/2011	US20110269735 Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
11/03/2011	US20110269732 Drug discovery methods
11/03/2011	US20110269707 Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation
11/03/2011	US20110269699 Cancer therapy
11/03/2011	US20110269691 Compositions and Methods for Treating Pigmentary Conditions and Melanoma
11/03/2011	US20110269688 Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same
11/03/2011	US20110269679 Inhibitors of amyloid fibril formation and uses thereof
11/03/2011	US20110269674 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
11/03/2011	US20110269648 Electrochemical sensor system
11/03/2011	US20110269647 Method
11/03/2011	US20110269643 Mass spectrometric methods for detecting mutations in a target nucleic acid
11/03/2011	US20110269639 Detection of Johnsongrass and Its Hybrid Seed
11/03/2011	US20110269637 Method for Predicting Clinical Outcome of Patients With Non-Small Cell Lung Carcinoma
11/03/2011	US20110269636 Materials and methods for identifying patients at heighten risk for developing her2+ related brain tumors
11/03/2011	US20110269634 Methods and Compositions for Risk Stratification
11/03/2011	US20110269633 Inflammatory biomarkers for monitoring depressive disorders
11/03/2011	US20110269179 Coliform detection process and kit for use therein
11/03/2011	US20110269178 Fluorescent cdk inhibitors for treatment of cancer
11/03/2011	US20110269177 Antimicrobial agent and method for the production thereof
11/03/2011	US20110269176 Methods for assaying responses to vaccines
11/03/2011	US20110269175 Methods for sorting particles
11/03/2011	US20110269174 Regulators of nfat
11/03/2011	US20110269173 Method for Producing Polarized Retinal Progenitor Cells from Pluripotent Stem Cells and their Differentiation into Retinal Pigment Epithelium Cells
11/03/2011	US20110269172 Micro-Electrode Grid Array for Top and Bottom Recording from Samples
11/03/2011	US20110269171 Methods and materials for using nkap polypeptide expression levels or patterns to detect or assess cancer
11/03/2011	US20110269170 pH Sensitive Metal Nanoparticle and Preparation Method
11/03/2011	US20110269169 Pseudomonas alcaliphila mbr and its application in bioreduction and biosorption
11/03/2011	US20110269168 Processes and kits for determining multi-drug resistance of cells
11/03/2011	US20110269167 Medical apparatus for extracorporeal blood treatment and method for determining a blood parameter value in a medical apparatus thereof
11/03/2011	US20110269166 Sealing surface sampling probe applied to blood spots and tissues
11/03/2011	US20110269165 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same
11/03/2011	US20110269164 Measuring Device, Measuring Method, and Program
11/03/2011	US20110269163 Method and medium for detecting the presence or absence of staphylococcus aureus in a test sample
11/03/2011	US20110269162 Ubiquitin proteasome system profiling for diagnosis of chronic liver disease
11/03/2011	US20110269161 Methods, Compositions and Kits for High Throughput Kinase Activity Screening Using Mass Spectrometry and Stable Isotopes
11/03/2011	US20110269160 Method and medium for detecting the presence or absence of staphylococcus aureus in a test sample
11/03/2011	US20110269150 Compositions and methods for predicting cardiovascular events
11/03/2011	US20110269145 Cancer Risk Biomarkers
11/03/2011	US20110269144 Ryanodine receptor polypeptides
11/03/2011	US20110269143 Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment
11/03/2011	US20110269142 Clinical Method for Individualized Epithelial Cancer Screening Involving ERCC5 and IGF2R Genetic Testing and Gene-Environment Interactions
11/03/2011	US20110269141 Target protein and target gene for drug discovery, and screening method
11/03/2011	US20110269140 Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
11/03/2011	US20110269139 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
11/03/2011	US20110269138 Method for detecting methicillin-resistant staphylococcus aureus (mrsa) strains
11/03/2011	US20110269137 Rapid and efficient assay to assess the sequence and size of 3' ends of polynucleotides
11/03/2011	US20110269136 Biomarker and composition for diagnosis of preeclampsia and method for using the same
11/03/2011	US20110269135 Device for analysing a chemical or biological sample
11/03/2011	US20110269134 Reagents and Methods for Detecting Neisseria Gonorrhoeae
11/03/2011	US20110269133 Compositions and Methods For Detecting The Presence Of Cryptosporidium Parvum In A Test Sample
11/03/2011	US20110269132 Methods for Determining Dysregulation of Methylation of Brain Expressed Genes on the X Chromosome to Diagnose Autism Spectrum Disorders
11/03/2011	US20110269131 Substrate for manufacturing disposable microfluidic devices
11/03/2011	US20110269130 Antibiotice Susceptibility Profiling Methods
11/03/2011	US20110269129 Binary probe system for sensitive detection of target analytes
11/03/2011	US20110269128 Forensic identification
11/03/2011	US20110269127 Means and method for determining tumor cell percentage in a sample
11/03/2011	US20110269126 Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders
11/03/2011	US20110269125 Methods and compositions for predicting development of atopic diseases
11/03/2011	US20110269124 Methods, Primers, Probes and Kits Useful for the Detection of BRAF Mutations
11/03/2011	US20110269123 Marker for gastric cancer and method for detecting gastric cancer
11/03/2011	US20110269122 Hereditary hemochromatosis gene
11/03/2011	US20110269121 Lab-on-a-pipette
11/03/2011	US20110269120 Methods and compositions for detecting promoter activity and expressing fusionproteins
11/03/2011	US20110269119 Encoding text into nucleic acid sequences
11/03/2011	US20110269118 Methods for identifying cells by combinatorial fluorescence imaging
11/03/2011	US20110269117 Methods For Direct Fluorescent Antibody Virus Detection In Liquids
11/03/2011	US20110269116 Cell Line From Rousettus As Host Cell For Pathogen Amplification
11/03/2011	US20110269115 Heated Assays for Influenza
11/03/2011	US20110268903 Methods of attaching biological compounds to solid supports using triazine
11/03/2011	US20110268767 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses
11/03/2011	US20110268753 Process for regulating immune response
11/03/2011	US20110268748 NURR-1 Interacting Protein (NuIP)
11/03/2011	US20110268742 Pctp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268716 Methods for the enrichment of viable foxp3+ cells and uses thereof

1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 3003